These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


229 related items for PubMed ID: 2652499

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A controlled trial comparing sequential antilymphocyte sera and cyclosporine therapy to conventional therapy in renal transplant recipients.
    Cardella CJ, Harding ME, deVeber GA, Honey J, Cook GT.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1996-7. PubMed ID: 3079065
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. An evaluation of early cyclosporine versus ALG therapy for primary cadaver renal allografts with immediate function.
    Adams MB, Johnson CP, Roza AM.
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1606-8. PubMed ID: 2652523
    [No Abstract] [Full Text] [Related]

  • 15. Sequential antilymphoblast globulin and cyclosporine for renal transplantation.
    Sommer BG, Henry ML, Ferguson RM.
    Transplant Proc; 1987 Feb; 19(1 Pt 3):1879-80. PubMed ID: 3274445
    [No Abstract] [Full Text] [Related]

  • 16. Low incidence of rejection and in vitro donor-specific hyporesponsiveness using pretransplant ALG, low-dose cyclosporine, and steroids in kidney cadaveric transplantation.
    Griñó JM, Bas J, Gonzalez C, Castelao AM, Seron D, Mestre M, Buendia E, Sabate R, Diaz C, Alsina J.
    Transplant Proc; 1990 Aug; 22(4):1367-8. PubMed ID: 2143855
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clinical management of immunosuppressive therapy for cyclosporine-treated recipients of cadaver kidney transplants at one to six months.
    Feduska NJ, Melzer J, Amend WJ, Vincenti F, Tomlanovich S, Salvatierra O.
    Transplant Proc; 1986 Apr; 18(2 Suppl 1):136-40. PubMed ID: 3515681
    [No Abstract] [Full Text] [Related]

  • 19. Sequential Minnesota antilymphoblast globulin and cyclosporine therapy after cadaver renal transplantation.
    Ludwin D, White N, Tsai S, Smith EK.
    Transplant Proc; 1985 Aug; 17(4):1943-4. PubMed ID: 3895635
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.